Cleared Traditional

Virtual C DRF-NEO Digital Imaging System (K212557) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K212557 · Portavision Medical, LLC · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2021
Decision
42d
Days
Class 2
Risk

K212557 is an FDA 510(k) clearance for the Virtual C DRF-NEO Digital Imaging System. Classified as Interventional Fluoroscopic X-ray System (product code OWB), Class II - Special Controls.

Submitted by Portavision Medical, LLC (Jefferson, US). The FDA issued a Cleared decision on September 24, 2021 after a review of 42 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1650 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Portavision Medical, LLC devices

Submission Details

510(k) Number K212557 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 13, 2021
Decision Date September 24, 2021
Days to Decision 42 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 107d · This submission: 42d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OWB Interventional Fluoroscopic X-ray System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1650
Definition Interventional Fluoroscopy
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Kamm & Associates
Daniel Kamm

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OWB Interventional Fluoroscopic X-ray System

All 185
Devices cleared under the same product code (OWB) and FDA review panel - the closest regulatory comparables to K212557.
VFSS Pro Mobile Digital Imaging System
K212523 · Imagexray, LLC · Nov 2021
nView s1 with nav option
K211064 · Nview Medical · Oct 2021
Zenition 70
K212813 · Philips Medical Systems Nederland B.V. · Oct 2021
EndoNaut
K212383 · Therenva Sas · Aug 2021
ARCO FP-S
K211777 · A.T.S. Applicazione Tecnologie Speciali S.R.L. · Aug 2021
Excelsius3D
K210912 · Globus Medical, Inc. · Aug 2021